Literature DB >> 8398213

Structure and function of proteins of the phosphotransferase system and of 6-phospho-beta-glycosidases in gram-positive bacteria.

W Hengstenberg1, D Kohlbrecher, E Witt, R Kruse, I Christiansen, D Peters, R Pogge von Strandmann, P Städtler, B Koch, H R Kalbitzer.   

Abstract

New information about the proteins of the phosphotransferase system (PTS) and of phosphoglycosidases of homofermentative lactic acid bacteria and related species is presented. Tertiary structures were elucidated from soluble PTS components. They help to understand regulatory processes and PTS function in lactic acid bacteria. A tertiary structure of a membrane-bound enzyme II is still not available, but expression of Gram-positive genes encoding enzymes II can be achieved in Escherichia coli and enables the development of effective isolation procedures which are necessary for crystallization experiments. Considerable progress was made in analysing the functions of structural genes which are in close vicinity of the genes encoding the sugar-specific PTS components, such as the genes encoding the tagatose-6-P pathway and the 6-phospho-beta-glycosidases. These phosphoglycosidases belong to a subfamily of the beta-glycosidase family I among about 300 different glycosidases. The active site nucleophile was recently identified to be Glu 358 in Agrobacterium beta-glucosidase. This corresponds to Glu 375 in staphylococcal and lactococcal 6-phospho-beta-galactosidase. This enzyme is inactivated by mutating Glu 375 to Gln. Diffracting crystals of the lactococcal 6-P-beta-galactosidase allow the elucidation of its tertiary structure which helps to derive the structures for the entire glycosidase family 1. In addition, a fusion protein with 6-phospho-beta-galactosidase and staphylococcal protein A was constructed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398213     DOI: 10.1111/j.1574-6976.1993.tb00016.x

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  7 in total

1.  Cloning and molecular analysis of a mannitol operon of phosphoenolpyruvate-dependent phosphotransferase (PTS) type from Vibrio cholerae O395.

Authors:  Sanath Kumar; Kenneth P Smith; Jody L Floyd; Manuel F Varela
Journal:  Arch Microbiol       Date:  2010-12-24       Impact factor: 2.552

2.  6-phospho-alpha-D-glucosidase from Fusobacterium mortiferum: cloning, expression, and assignment to family 4 of the glycosylhydrolases.

Authors:  C L Bouma; J Reizer; A Reizer; S A Robrish; J Thompson
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

3.  Analysis of the mechanism and regulation of lactose transport and metabolism in Clostridium acetobutylicum ATCC 824.

Authors:  Yang Yu; Martin Tangney; Hans C Aass; Wilfrid J Mitchell
Journal:  Appl Environ Microbiol       Date:  2007-01-05       Impact factor: 4.792

4.  Phospho-beta-glucosidase from Fusobacterium mortiferum: purification, cloning, and inactivation by 6-phosphoglucono-delta-lactone.

Authors:  J Thompson; S A Robrish; C L Bouma; D I Freedberg; J E Folk
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

5.  Cloning and sequencing of two genes from Staphylococcus carnosus coding for glucose-specific PTS and their expression in Escherichia coli K-12.

Authors:  I Christiansen; W Hengstenberg
Journal:  Mol Gen Genet       Date:  1996-02-25

6.  CcpA represses the expression of the divergent cit operons of Enterococcus faecalis through multiple cre sites.

Authors:  Cristian A Suárez; Víctor S Blancato; Sandrine Poncet; Josef Deutscher; Christian Magni
Journal:  BMC Microbiol       Date:  2011-10-11       Impact factor: 3.605

7.  Recovery of the Peptidoglycan Turnover Product Released by the Autolysin Atl in Staphylococcus aureus Involves the Phosphotransferase System Transporter MurP and the Novel 6-phospho-N-acetylmuramidase MupG.

Authors:  Robert Maria Kluj; Patrick Ebner; Martina Adamek; Nadine Ziemert; Christoph Mayer; Marina Borisova
Journal:  Front Microbiol       Date:  2018-11-16       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.